AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

Rodríguez-Baño, Jesús, Rossolini, Gian Maria, Schultsz, Constance, Tacconelli, Evelina, Murthy, Srinivas, Ohmagari, Norio, Holmes, Alison, Bachmann, Till, Goossens, Herman, Canton, Rafael, Roberts, Adam ORCID: https://orcid.org/0000-0002-0760-3088, Henriques-Normark, Birgitta, Clancy, Cornelius J., Huttner, Benedikt, Fagerstedt, Patriq, Lahiri, Shawon, Kaushic, Charu, Hoffman, Steven J., Warren, Margo, Zoubiane, Ghada, Essack, Sabiha, Laxminarayan, Ramanan and Plant, Laura (2021) 'AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic'. Journal of Global Antimicrobial Resistance, Vol 25, pp. 5-7.

Preview

Text 1-s2.0-S221371652100045X-main.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview

Abstract

Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.

Item Type:	Article
Subjects:	QW Microbiology and Immunology > Viruses > QW 160 Viruses (General). Virology QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. WB Practice of Medicine > Therapeutics > WB 330 Drug therapy WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 505 Viral respiratory tract infections WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 518 Respirovirus Infections
Faculty: Department:	Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI):	https://doi.org/10.1016/j.jgar.2021.02.013
Depositing User:	Stacy Murtagh
Date Deposited:	09 Mar 2021 16:22
Last Modified:	06 Apr 2021 14:47
URI:	https://archive.lstmed.ac.uk/id/eprint/17219

Statistics

View details

Actions (login required)

Edit Item